Indian peripheral neuropathy treatment Market is Expected to grow at a CAGR of 5.8% During Forecast 2020-2026
Indian peripheral neuropathy treatment market is estimated to grow at a CAGR of 5.8% during the forecast period. The rising prevalence of diabetes is a major factor in accelerating market growth. As per the International Diabetes Federation (IDF), In India, the total cases of diabetes in adults were nearly 77 million in 2019. The most common diabetic complication is peripheral neuropathy. It is a severe diabetic complication that may affect nearly 50% of people suffering from diabetes. This condition affects the legs and feet first and is followed by hands and arms. This results in an increasing demand for diabetic peripheral neuropathy treatment in the country. Some antidepressants provide ease to nerve pain. Tricyclic antidepressants may support mild to moderate nerve pain. This class of drugs includes imipramine (Tofranil), amitriptyline, and desipramine (Norpramin).
To Request a Sample of our Report on Indian peripheral
neuropathy treatment Market: https://www.omrglobal.com/request-sample/indian-peripheral-neuropathy-treatment-market
Indian peripheral neuropathy
treatment market is segmented based on type and application. Based on type, the
market is classified into antidepressants, pain relievers, antiseizure, and
others. Based on the application, the market is classified into diabetes,
chemotherapy-induced, and others. Rising cancer prevalence is leading to
increasing demand for chemotherapy in the country. As per the World Health
Organization (WHO), the number of new cancer incidences in India was nearly 1.1
million in 2018. This, in turn, is resulting in the demand for
chemotherapy-induced peripheral neuropathy treatment in the country.
(Get 15% Discount on Buying this Report)
A
full Report of Indian peripheral neuropathy treatment Market is Available
at: https://www.omrglobal.com/industry-reports/indian-peripheral-neuropathy-treatment-market
Indian Peripheral Neuropathy Treatment Market
Segmentation
By Type
·
Antidepressants
·
Pain Relievers
·
Antiseizure
·
Others
By Application
·
Diabetes
·
Chemotherapy-Induced
·
Others
Company Profiles
·
Alembic Pharmaceuticals Ltd.
·
Product Analysis
·
Recent Developments
·
Alkem Laboratories Ltd.
·
Cipla Ltd.
·
Dr Reddy’s Laboratories Ltd.
·
Eli Lilly and Co.
·
Glenmark Pharmaceuticals Ltd.
·
Laurus Labs Ltd.
·
Lupin Ltd.
·
Pfizer Inc.
·
Teva Pharmaceutical Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment